Vimarsana
Biggest News Aggregation in the World

Page 12 - Rating Scale News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rating Scale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rating Scale Today - Breaking & Trending Today

Add-On Vraylar Tied to Easing of Recurrent Depressive Symptoms - Vimarsana News

Add-On Vraylar Tied to Easing of Recurrent Depressive Symptoms

Data show safety and efficacy of agent when paired with first-line antidepressants

Eledon Pharmaceuticals, Inc's (ELDN) CEO David-Alexandre Gros on Q1 2022 Results - Earnings Call Transcript - Vimarsana News

Eledon Pharmaceuticals, Inc's (ELDN) CEO David-Alexandre Gros on Q1 2022 Results - Earnings Call Transcript

Eledon Pharmaceuticals, Inc. (NASDAQ:NASDAQ:ELDN) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Paul Little – Chief Financial Officer David-Alexandre Gros –...

Oral Suspension Formulation of Edaravone Approved for ALS - Vimarsana News

Oral Suspension Formulation of Edaravone Approved for ALS

The FDA has approved Radicava ORS (edaravone) oral suspension for the treatment of adults with amyotrophic lateral sclerosis.

Source: empr.com
Low-Dose ADHD Medications Not Associated With Changes in Thyroid and Growth Hormones in Children - Vimarsana News

Low-Dose ADHD Medications Not Associated With Changes in Thyroid and Growth Hormones in Children

Study finds that low-dose medications for ADHD are not associated with changes in thyroid or growth hormone levels among children aged 6 to 12 years.

Low-Dose ADHD Medications Not Associated With Changes in Thyroid and Growth Hormones in Children - Vimarsana News

Low-Dose ADHD Medications Not Associated With Changes in Thyroid and Growth Hormones in Children

Study finds that low-dose medications for ADHD are not associated with changes in thyroid or growth hormone levels among children aged 6 to 12 years.